#clinical - Techseriesinsight

June 12, 2025
PRNewswire
Healthcare

CRAACO Conference Focuses on Getting More Clinical Trials Into Healthcare Systems

The Conference Forum announced today the launch of the 10th annual CRAACO®: Clinical Research as a Care Option conference, taking place September 15, 2025 at the Loews Philadelphia Hotel in Philadelphia, PA....

June 12, 2025
PRNewswire
Data Management Platform

MRO Acquires Enterprise Clinical Data Management Platform Q-Centrix

MRO Corp. (MRO), the leading clinical data exchange company in healthcare, announced today the acquisition of Q-Centrix Corp. (Q-Centrix), a leading enterprise clinical data management platform, enabling hospitals and...

June 12, 2025
PRNewswire
Healthcare

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, “NRx” or the “Company”), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., (“HOPE,” or the “Company”), a multi-site clinical care delivery organization and...

June 12, 2025
PRNewswire
Biotechnology

Sobi share new clinical data across multiple hematologic diseases at EHA 2025

Sobi® (STO: SOBI) will present data at the 30th EHA (European Haematology Association) hybrid congress, in Milan, Italy (12-15 June). The congress will feature the latest advances in the treatment of diffuse...

June 11, 2025
PRNewswire
Biotechnology

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biotechnology company pioneering gamma delta T cell therapies for the treatment of cancer, today announced the first patient treated in Cohort B, presenting with detectable...

June 11, 2025
PRNewswire
Healthcare

Cyrano Therapeutics to Participate in 2025 BIO International Convention

Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, today announced its participation in the 2025 BIO International Convention, to be held...

June 9, 2025
PRNewswire
Biotechnology

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its plant-derived, Type I recombinant human collagen (rhCollagen) for tissue regeneration and medical...

June 5, 2025
PRNewswire
Healthcare

Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of Paxalisib in Advanced Breast Cancer

Kazia Therapeutics Limited (NASDAQ: KZIA) (“Kazia” or the “Company”), an oncology-focused biotechnology company developing innovative therapies for difficult-to-treat cancers, today announced that the first patient has been dosed in a...

June 2, 2025
PRNewswire
Biotechnology

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that Dr. Steven Quay, M.D., Ph.D., President and Chief Executive Officer,...

May 29, 2025
PRNewswire
Biotechnology

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson’s Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases,...